Skip to content

Continuous infusion of Esmolol in patients undergoing CABG surgery

Comparison study of continuous infusion and bolus of Esmolol on hemodynamic response to laryngoscopy and endotracheal intubation in coronary artery bypass graft patients

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200822048478N2
Enrollment
66
Registered
2020-10-04
Start date
2015-07-23
Completion date
Unknown
Last updated
2020-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary artery disease. Atherosclerotic heart disease of native coronary artery

Interventions

Intervention 1: Infusion group: 0.5 mg/kg Esmolol is injected within 4 minutes and then the infusion is started at 200 µg/kg/min and continues until endotracheal intubation. 0.9% Nacl is administered

Sponsors

Kashan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with ASA 2-4 undergoing elective CABG surgery EF>40%

Exclusion criteria

Exclusion criteria: AV conduction block greater than grade 1 asthma acute MI HR<50 Mallampati score greater than 2 Kidney or liver failure History of allergy or Idiosyncratic reaction to ß-blockers Systolic blood pressure less than 100 mmHg Diastolic blood pressure less than 50 mmHg

Design outcomes

Primary

MeasureTime frame
Heart rate. Timepoint: HR and systolic blood pressure and diastolic blood pressure and mean blood pressure before infusion to induction, during and after induction of anesthesia, at laryngoscopy and endotracheal intubation and every minute for 10 minutes after endotracheal intubation are recorded. Method of measurement: After entering the operating room, patients are monitored by pulse oximeter, electrocardiogram and non-invasive blood pressure.To monitor blood pressure invasively, an intra-arterial catheter is inserted into the left radial artery after local injection of Lidocaine.;Systolic blood pressure. Timepoint: HR and systolic blood pressure and diastolic blood pressure and mean blood pressure before infusion to induction, during and after induction of anesthesia, at laryngoscopy and endotracheal intubation and every minute for 10 minutes after endotracheal intubation are recorded. Method of measurement: After entering the operating room, patients are monitored by pulse oximeter, electrocardiogram and non-invasive blood pressure.To monitor blood pressure invasively, an intra-arterial catheter is inserted into the left radial artery after local injection of Lidocaine.;Diastolic blood pressure. Timepoint: HR and systolic blood pressure and diastolic blood pressure and mean blood pressure before infusion to induction, during and after induction of anesthesia, at laryngoscopy and endotracheal intubation and every minute for 10 minutes after endotracheal intubation are recorded. Method of measurement: After entering the operating room, patients are monitored by pulse oximeter, electrocardiogram and non-invasive blood pressure.To monitor blood pressure invasively, an intra-arterial catheter is inserted into the left radial artery after local injection of Lidocaine.;Mean blood pressure. Timepoint: HR and systolic blood pressure and diastolic blood pressure and mean blood pressure before infusion to induction, during and after induction of anesthesia, at laryngoscopy

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHosein Akbari

Kashan University of Medical Sciences

akbari1350_h@yahoo.com+98 31 5554 0021

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026